IndraLab

Statements

VLX1570 activates UCHL5. 2 / 2

| 2

reach

"The small-molecule inhibitor VLX1570 and its analog b-AP15 specifically inhibit the activity of USP14 and Ubiquitin Carboxyl-Terminal Hydrolase L5 (UCHL5) within the 19S regulatory subunit."

39391247

➶

reach

"The first DUB inhibitor VLX1570 is a dual inhibitor for USP14 and UCHL5, which started its clinical drug trials in 2015 (86)."

37795365

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

VLX1570 activates UCHL5. 2 / 2

INDRA sources:

Databases

Reading